A federal judge opted not to rule on a lawsuit seeking to overturn US Food & Drug Administration (FDA) approval of mifepristone until the FDA completes a review that has been described as a political pretext to restrict abortion.
Access to mifepristone will remain unchanged in the US for now after a federal district judge paused a lawsuit aimed at overturning the Food and Drug Administration’s approval of the medication. But he left the door open for the Trump administration to restrict access to the drug at the end of the review if justified.
US District Judge Reed O’Connor of the Northern District of Texas refused the manufacturer’s motion to dismiss a lawsuit brought by Texas and Florida seeking to overturn FDA approval of mifepristone altogether. But the judge accepted the US Department of Justice’s (DOJ) motion to stay the case until December 1, or until the FDA completes a “review” of the drug that it will use to determine whether access to it should be tightened.
SOURCE: Common Dreams by Stephen Prager. 31 August 2026. https://www.commondreams.org/news/texas-florida-mifepristone-ruling.